Godavari Drugs
Godavari Drugs Share Price Chart
Godavari Drugs last traded at ₹139.95 (2026-10-13). Over the past month the stock moved +17.6%, three months the stock moved +8.6%, year the stock moved +63.8%. Its closing range over 52 weeks is ₹71.39 – ₹140.00, with the latest close at its 52-week high.
Closing prices up to 2026-10-13.
About Godavari Drugs
Incorporated in 1987, Godavari Drugs Ltd manufactures and sale of Active Pharmaceutical Ingredients and their intermediates[1]
Business Overview:[1] GDL is in the business of manufacturing of APls, intermediates and fine chemicals as per the requirements of the global life science industry. It also explores Loan licenses and Contract Manufacturing tie-ups with reputed multinational co. for Narcotic Products, API and drug intermediates, to partners who have such requirements.
Fundamentals
Quarterly Results
In the latest quarter (Jun 2026), Godavari Drugs reported sales of ₹27.96 crore (+17.4%) and net profit of ₹1.11 crore (+6.7%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 27.96 | 2.52 | 9.01 | 1.11 | 1.10 |
| Mar 2026 | 33.16 | 2.94 | 8.87 | 1.29 | 1.27 |
| Dec 2025 | 22.18 | 2.47 | 11.14 | 0.76 | 1.01 |
| Sep 2025 | 26.65 | 2.00 | 7.50 | 1.00 | 1.33 |
| Jun 2025 | 23.81 | 2.90 | 12.18 | 1.04 | 1.38 |
| Mar 2025 | 25.50 | 3.11 | 12.20 | 0.89 | 1.18 |
| Dec 2024 | 29.55 | 2.58 | 8.73 | 0.77 | 1.02 |
| Sep 2024 | 26.09 | 2.90 | 11.12 | 1.09 | 1.45 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | -34.0% | -31.5% | -34.0% | -26.1% | +2.1% | -24.9% | +30.0% | +17.4% |
| Operating profit growth | -5.5% | -26.7% | -30.4% | -10.2% | -31.0% | -4.3% | -5.5% | -13.1% |
| Net profit growth | +26.7% | -36.9% | -66.5% | -36.2% | -8.3% | -1.3% | +44.9% | +6.7% |
| EPS growth | +27.2% | -37.0% | -66.6% | -36.1% | -8.3% | -1.0% | +7.6% | -20.3% |
| OPM % | 11.1% | 8.7% | 12.2% | 12.2% | 7.5% | 11.1% | 8.9% | 9.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Annual Financials
In the latest year (Mar 2026), Godavari Drugs reported sales of ₹106.00 crore (-6.2%) and net profit of ₹4.00 crore (+0.0%), compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 106.00 | 10.00 | 10.00 | 4.00 | 4.04 |
| Mar 2025 | 113.00 | 12.00 | 10.00 | 4.00 | 5.82 |
| Mar 2024 | 157.00 | 13.00 | 8.00 | 6.00 | 7.37 |
| Mar 2023 | 160.00 | 10.00 | 6.00 | 4.00 | 5.03 |
| Mar 2022 | 161.00 | 11.00 | 7.00 | 5.00 | 6.97 |
| Mar 2021 | 123.00 | 10.00 | 8.00 | 4.00 | 5.48 |
| Mar 2020 | 96.00 | 6.00 | 6.00 | 2.00 | 2.66 |
| Mar 2019 | 84.00 | 5.00 | 7.00 | 1.00 | 1.61 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +31.3% | +14.3% | +28.1% | +30.9% | -0.6% | -1.9% | -28.0% | -6.2% |
| Operating profit growth | +25.0% | +20.0% | +66.7% | +10.0% | -9.1% | +30.0% | -7.7% | -16.7% |
| Net profit growth | +0.0% | +100.0% | +100.0% | +25.0% | -20.0% | +50.0% | -33.3% | +0.0% |
| EPS growth | +46.4% | +65.2% | +106.0% | +27.2% | -27.8% | +46.5% | -21.0% | -30.6% |
| OPM % | 7.0% | 6.0% | 8.0% | 7.0% | 6.0% | 8.0% | 10.0% | 10.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
Shareholding
AI Analysis
No AI analysis generated yet for Godavari Drugs.
Get Free AI Stock Analysis FREE →Latest News
-
Godavari Drugs standalone net profit rises 44.94% in the March 2026 quarter - Business Standard
Frequently Asked Questions
What is the share price of Godavari Drugs today?
Godavari Drugs shares were last quoted at ₹139.95 (-0.0% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
What is the P/E ratio of Godavari Drugs?
Godavari Drugs has a price-to-earnings (P/E) ratio of 30.46 and a price-to-book (P/B) ratio of 1.65. The industry P/E is 53.33.
What is the 52-week high and low of Godavari Drugs?
The 52-week high of Godavari Drugs is ₹135.25 and the 52-week low is ₹69.70.
What is the market cap of Godavari Drugs?
The market capitalisation of Godavari Drugs is about ₹126.78 crore.
How did Godavari Drugs perform in its latest quarterly results?
In the latest quarter (Jun 2026), Godavari Drugs reported sales of ₹27.96 crore (+17.4%) and net profit of ₹1.11 crore (+6.7%), compared with the same quarter last year.
Is Godavari Drugs a good stock to buy?
This page is for information and is not investment advice. As per the data shown here, Godavari Drugs has a 3-year ROE of 10.00%, 3-year profit growth of 2.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
What is the promoter holding in Godavari Drugs?
Promoters hold about 40.23% of Godavari Drugs.
Which sector does Godavari Drugs belong to?
Godavari Drugs belongs to the Pharmaceuticals & Drugs sector.